Amikacin inhalation solution BAY41-6551
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Amikacin inhalation solution BAY41-6551, covering 2018-06-26 to 2018-06-26. Get the full timeline:
Most recent: Clinical Trial Update: Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia [Phase 3]